Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin-Yang Li

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
Cancer|July 11, 2006
Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trialAlvaro Moreno-Aspitia, Gerardo Colon-Otero, Antje Hoering, et al.
Blood|July 31, 2004
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaAnimesh Pardanani, Stephanie R Brockman, Sarah F Paternoster, et al.
Cancer|April 19, 2007
Clinical correlates of JAK2V617F allele burden in essential thrombocythemiaJaya Kittur, Ryan A Knudson, Terra L Lasho, et al.
Blood|January 9, 2003
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasiaRuben A Mesa, David P Steensma, Animesh Pardanani, et al.
Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Blood|October 24, 2002
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control studyCatherine Metayer, Rochelle E Curtis, Julie Vose, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
Cancer|July 11, 2006
Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trialAlvaro Moreno-Aspitia, Gerardo Colon-Otero, Antje Hoering, et al.
Blood|July 31, 2004
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaAnimesh Pardanani, Stephanie R Brockman, Sarah F Paternoster, et al.
Cancer|April 19, 2007
Clinical correlates of JAK2V617F allele burden in essential thrombocythemiaJaya Kittur, Ryan A Knudson, Terra L Lasho, et al.
Blood|January 9, 2003
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasiaRuben A Mesa, David P Steensma, Animesh Pardanani, et al.
Blood|July 5, 2003
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapyAnimesh Pardanani, Rhett P Ketterling, Stephanie R Brockman, et al.
Blood|October 24, 2002
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control studyCatherine Metayer, Rochelle E Curtis, Julie Vose, et al.
Pageof 6